Azzalure (Single vial)

Azzalure is an anti-wrinkle injection and prescription-only medicine. It’s specifically designed for aesthetic use. Azzalure has an active ingredient called Botulinum toxin type A,   which effectively reduces moderate to severe Glabellar lines (vertical lines between the eyebrows) and Lateral canthal lines (crow’s feet lines) lessening the appearance of vertical frown lines. The effect is only temporary and further treatments can be given every three months.

This is a prescription only medicine and should only be administered by trained medical professionals with the requisite experience in the application of Botulinum toxin type A.l

Please note: this is a prescription only item, and requires a prescription from a UK prescriber before dispatch 

Box Contents:

Each box contains x1 Azzalure 125UI Vial

Composition:

One vial contains 125 Speywood units. - The other ingredients are human albumin 200g/L and lactose monohydrate. *Clostridium botulinum (a bacteria) toxin A haemagglutinin complex. The Speywood units of Azzalure are specific to the product and are not interchangeable with other treatments containing botulinum toxin

Key Features:

Relaxes the muscles to prevent contractions

Blocks transport of the neurotransmitter acetylcholine across the neuromuscular junction, located between the nerve end and the muscle fibre

Used in the treatment of moderate to severe wrinkles in patients

Treatment Areas: 

Forehead 

Crows feet 

Frown lines

Masseter muscle 

Bunny lines 

Glabellar lines 

Chin

Lip flip 

Armpit

Contraindications of Azzalure:

Hypersensitivity to the active substance or any of the excipients

Presence of infection at the proposed injection sites

Presence of myasthenia gravis, Eaton Lambert Syndrome or amyotrophic lateral sclerosis

Who Should Not Use Azzalure? 

Pregnant and lactating women should not use this product as not enough clinical data has been collected to suggest that it is safe. There is a risk of this product passing through the mother to her baby

Any individuals who develop hypersensitivity or an allergic reaction to the product should also refrain from using it. Children under 18 and adults over 65 should also not use this product

Anyone with an infection on the skin surface at the proposed injection site should wait for the infection to completely disappear first

If there is a probable muscle weakness (myasthenia gravis) already present, then do not use Azzalure either. The following diseases and conditions should also rule out the use of this medicine: Eaton Lambert syndrome and amyotrophic lateral sclerosis (degenerative nerve muscle disorder)

Duration:

Up to 3 - 4 months

Storage Temp:

Store Azzalure in a refrigerator 2 - 8˚C

For use by trained professionals only